Dr. Andrea Apollo On Avelumab And Its Effect On Locally Advanced Or Metastatic Urothelial Carcinoma

Dr. Andrea Apollo On Avelumab and its Effect on Locally Advanced or Metastatic Urothelial Carcinoma

Dr. Apolo on Avelumab for Metastatic Urothelial Carcinoma

Dr. Andrea Apolo on Avelumab in Metastatic Bladder Cancer

Dr. Andrea Apolo on Treatment Challenges in Metastatic Bladder Cancer

Updated Efficacy Results for Avelumab in Metastatic Urothelial Carcinoma

Targeted Oncology

Dr. Apolo on Updated JAVELIN Results of Avelumab in Urothelial Carcinoma

AMBASSADOR: pembrolizumab for locally advanced bladder cancer

Avelumab in locally advanced or metastatic solid tumors

Unmet needs in bladder cancer in the immunotherapy era

Pooled Analysis of Avelumab in Bladder Cancer

Cancer Therapy Advisor

Andrea Apolo, M.D. - Spotlight on Scientists

National Cancer Institute

JAVELIN: safety and efficacy 2-year follow up

Avelumab Plus Best Supportive Care Shows Efficacy in Urothelial Carcinoma

Targeted Oncology

Managing Avelumab Side Effects in Patients With Merkel Cell Carcinoma

Dr. Apolo on Managing Toxicities of Checkpoint Inhibitors in Bladder Cancer

JAVELIN Bladder 100: avelumab shows OS benefit for bladder cancer

Genomics-led therapy assignment with COXEN in advanced/metastatic urothelial carcinoma

Immunotherapy for Bladder Cancer Review With Dr. Andrea Apolo—PracticeUpdate's ESMO Coverage

Avelumab Maintenance for Advanced Urothelial Carcinoma

Advances in Bladder Cancer With Andrea Apolo

Chadi Nabhan and Healthcare Unfiltered